IMPARC
Phase NA Terminated
15 enrolled 16 charts
COCHISE
Phase 2 Terminated
18 enrolled 9 charts
Genetic Testing in Screening Patients With Metastatic or Unresectable Colon or Rectal Cancer for a COLOMATE Trial
Terminated
199 enrolled 8 charts
SAFE-2
Phase NA Terminated
18 enrolled 10 charts
Endoscopic Optical Coherence Tomography for Screening and Diagnosis of Colorectal Precancerous and Malignant Polyps
Phase NA Terminated
36 enrolled 9 charts
Testing the Addition of a Radiation Sensitizing Drug, IPdR, to the Usual Chemotherapy Treatment (Capecitabine) During Radiation Therapy for Rectal Cancer
Phase 1 Terminated
1 enrolled 7 charts
Talimogene Laherparepvec, Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Locally Advanced or Metastatic Rectal Cancer
Phase 1 Terminated
3 enrolled 9 charts
Blue and Amber Light Exposure in Patients With Rectal and Pancreatic Cancer
Phase NA Terminated
2 enrolled 4 charts
Ipilimumab and Local Radiation for Selected Solid Tumors
Phase 1 Terminated
3 enrolled 5 charts
Savolitinib in Treating Patients With MET Amplified Metastatic or Unresectable Colorectal Cancer
Phase 2 Terminated
5 enrolled 8 charts
Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer
Phase 1 Terminated
7 enrolled 8 charts
Radiation Therapy and Capecitabine With or Without Curcumin Before Surgery in Treating Patients With Rectal Cancer
Phase 2 Terminated
22 enrolled 16 charts
Sacral Nerve Stimulation in Treating Low Anterior Resection Syndrome or Fecal Incontinence in Patients With Locally Advanced Rectal Cancer or Other Pelvic Cancer, the RESTORE Study
Phase 2 Terminated
3 enrolled 5 charts
Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer
Phase 3 Terminated
355 enrolled 11 charts
Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer
Phase 1/2 Terminated
82 enrolled 14 charts
PET/MR for Rectal Cancer Treatment Monitoring and Surveillance
Phase NA Terminated
14 enrolled 6 charts
Pilot Trial of Resistant Starch in Stage I-III Colorectal Cancer Survivors
Phase 2 Terminated
10 enrolled 15 charts
SentiRect
Phase NA Terminated
15 enrolled 14 charts
Exploratory Study of TG02-treatment as Monotherapy or in Combination With Pembrolizumab to Assess Safety and Immune Activation in Patients With Locally Advanced Primary and Recurrent Oncogenic RAS Exon 2 Mutant Colorectal Cancer
Phase 1 Terminated
6 enrolled 11 charts
Chemoembolization Using Irinotecan in Treating Patients With Liver Metastases From Metastatic Colon or Rectal Cancer
Phase 1 Terminated
4 enrolled 6 charts
A Phase I Study of AZD6244 in Combination With Capecitabine and Radiotherapy in Locally Advanced Adenocarcinoma of the Rectum
Phase 1 Terminated
1 enrolled 7 charts
GCC 1314
Phase 2 Terminated
3 enrolled 8 charts
Study of Bevacizumab Combined With Capecitabine and Either Oxaliplatin or Irinotecan as First Course of Treatment for Patients With Colorectal Cancer That Has Spread Beyond the Colon
Phase 2 Terminated
7 enrolled 5 charts
Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
Phase NA Terminated
3 enrolled 8 charts
BrUOG 302:BYL719, Capecitabine and Radiation for Rectal Cancer: A Brown University Oncology Research Group Study
Phase 1 Terminated
7 enrolled 7 charts
Neoadjuvant Chemoradiotherapy With CRLX-101 and Capecitabine for Rectal Cancer
Phase 1/2 Terminated
32 enrolled 18 charts
PILLAR III
Phase NA Terminated
347 enrolled 18 charts
MK-0646-025
Phase 2 Terminated
11 enrolled 8 charts
Phase II Trial of Neoadjuvant FOLFOX4 and Cetuximab for Localized Adenocarcinoma of Rectum
Phase 2 Terminated
6 enrolled 7 charts
Selenium for Prevention of Adenomatous Colorectal Polyps
Phase 3 Terminated
1,621 enrolled 12 charts
AZD0530 (NSC 735464) in Treating Patients With Previously Treated Metastatic Colon Cancer or Rectal Cancer
Phase 2 Terminated
10 enrolled 7 charts
Cetuximab, 5-FU and Radiation as Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer
Phase 2 Terminated
13 enrolled 9 charts
PARAGON
Phase 1/2 Terminated
4 enrolled 5 charts
FC-4
Phase 2 Terminated
4 enrolled 9 charts
Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses
Phase NA Terminated
258 enrolled 10 charts
Neo-Adjuvant FOLFOX for Rectal Carcinoma
Phase 2 Terminated
2 enrolled 4 charts
Sacral Neuromodulation (SNM) With InterStimTM for Bowel Dysfunction Following Surgery for Rectal Cancers With Sphincter Preservation
Phase 2/3 Terminated
4 enrolled 5 charts
ADAPT
Phase 2 Terminated
27 enrolled 10 charts
A Phase 1-2 Trial of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-advanced Rectal Cancer
Phase 1/2 Terminated
23 enrolled 18 charts
Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer
Phase 3 Terminated
32 enrolled 14 charts
Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer
Phase 2 Terminated
7 enrolled 1 chart
Capecitabine, Oxaliplatin, Selenomethionine, and Radiation Therapy in Treating Patients Undergoing Surgery For Newly Diagnosed Stage II or III Rectal Adenocarcinoma
Phase 2 Terminated
5 enrolled 6 charts
Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer
Phase 2 Terminated
25 enrolled 10 charts
Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab
Phase 2 Terminated
5 enrolled 5 charts
Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A)
Phase 2 Terminated
65 enrolled 8 charts
Intensity Modulated Radiation Therapy (IMRT) for Patients With Rectal Cancer
Phase 2 Terminated
2 enrolled 4 charts
Combination Chemotherapy and Bevacizumab Before Surgery and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer
Phase 2 Terminated
1 enrolled 2 charts
Inositol in Preventing Colorectal Cancer in Patients With Colitis-Associated Dysplasia
Phase 1/2 Terminated
5 enrolled 7 charts
Capecitabine + Irinotecan Followed by Combined Modality Capecitabine and Radiation in Locally Advanced Rectal Cancer
Phase 2 Terminated
22 enrolled 10 charts
Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer
Phase 3 Terminated
11 enrolled 7 charts